Fibromyalgia

banner image

Introducing Fibromyalgia


Unlike pain from injury or inflammation, Fibromyalgia pain is believed to stem from amplified pain signals in the brain and spinal cord, a phenomenon known as central sensitization. 


Individuals with fibromyalgia often experience an increased sensitivity to pain, where non-painful stimuli can be perceived as painful.


This chronic pain can significantly interfere with daily life, impacting work, relationships, and overall quality of life. 


The exact cause remains elusive, but research suggests a combination of genetic predisposition, infections, physical or emotional trauma, and stress can contribute to its development.



Conventional Approaches to Managing Fibromyalgia


Traditional management strategies for Fibromyalgia aim to alleviate symptoms and improve quality of life.


Prescribed drugs may include pain relievers (over-the-counter or prescription), antidepressants (to help with pain, fatigue, and sleep), and anti-seizure drugs (which can reduce certain types of pain). 


While these conventional treatments offer relief for many, a significant number of individuals with Fibromyalgia continue to struggle with persistent pain and other symptoms, often seeking alternative or complementary therapies due to insufficient efficacy or undesirable side effects from medications.

 

More about Deep TMS for Fibromyalgia?

The Deep TMS Approach to Fibromyalgia

BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS™) is an innovative, non-invasive neurostimulation therapy that offers a promising avenue for managing chronic pain conditions, including fibromyalgia. 


While the precise mechanisms are still being researched, Deep TMS works by delivering magnetic pulses to specific, deeper, and broader areas of the brain that are implicated in pain processing, emotional regulation, and brain connectivity, which are often dysregulated in Fibromyalgia.


In a key randomized, double-blind trial, Deep TMS was shown to produce a 40.4% relative reduction in pain—a dramatic improvement compared to the control group. 


Furthermore, one study found a 99.4% probability that patients would achieve a clinically meaningful pain reduction of 50% or greater, highlighting the therapy's powerful efficacy.

Attention!

You are viewing a page that is not intended for persons in the United States, and includes information about treatment applications that HAVE NOT BEEN CLEARED by the FDA for safety and efficacy.


However, BrainsWay Deep TMS™ has received the European CE Mark for the treatment of many conditions.

 

This significant approval underscores the therapy's established safety and efficacy for these indications in Europe. While regulatory statuses vary by region, this CE Mark highlights the recognized potential of Deep TMS as a therapeutic option for:


Major Depressive Disorder (MDD)

Anxiety Depression

Obsessive-Compulsive Disorder (OCD)

Smoking Cessation

Alzheimer's Disease (AD)

Autism

Bipolar Disorder

Chronic Pain

Multiple Sclerosis (MS)

Parkinson's Disease

Post-Stroke Rehabilitation

Post-Traumatic Stress Disorder (PTSD)

Negative Symptoms of Schizophrenia

  



See What they said

"I feel different, my cognitive abilities are back, and now I'm enjoying life and even planning to go back to school." 

 — BrainsWay Deep TMS®  Patient 

"My experience with TMS has profoundly changed my life."

— BrainsWay Deep TMS®  Patient

"Feeling in the moment, enjoying life.Now I'm just leading a great life, thanks to  BrainsWay Deep TMS®  for OCD."

— BrainsWay Deep TMS®  Patient